Moreover, for patients with higher baseline IL-6, FLV treatment resulted in a significant reduction in IL-6 levels, which provided preliminary evidence for the individual treatment of patients with MDD with higher inflammation. This evidence concerns the gene IL6 and major depressive disorder.